Catheter Precision (VTAK) announced the launch of its LockeT suture retention device in Switzerland. The first clinical cases were performed at Spitalzentrum Biel, led by PD Dr. Rainer Zbinden, with excellent procedural outcomes and positive feedback from both the clinical and nursing teams. This milestone follows the company’s recent strategic distribution agreement with FuMedica AG, a premier Swiss medical device distributor with a strong presence in cardiovascular and interventional medicine. The partnership enables the introduction of LockeT to hospitals and clinics across Switzerland, further expanding Catheter Precision’s European footprint.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision announces addition of key ablation procedures to ASC by CMS
- Catheter Precision Ends At-Market-Offering Agreement
- Catheter Precision announces successful LockeT launch in South Africa
- Catheter Precision announces third VIVO installation in France
- Catheter Precision enters distribution agreement with FuMedica